Zobrazeno 1 - 10
of 38
pro vyhledávání: '"M. Järnmark"'
Autor:
Eva Kimby, Jan Liliemark, Magnus Björkholm, Astrid Gruber, Andreas Killander, Gunnar Juliusson, M. Järnmark, G. Grimfors, R. Hast, G. Gahrton
Publikováno v:
European Journal of Haematology. 55:19-23
Complex-binding of anthracyclines to DNA may increase their therapeutic efficacy. In a previous randomized trial patients with acute myelocytic leukaemia (AML) receiving combination chemotherapy including a DNA-bound doxorubicin preparation had a lon
Autor:
Bo Nilsson, Håkan Mellstedt, Bengt Smedmyr, H. Gyllenhammar, Bertil Johansson, Richard A. Lerner, Anders Österborg, C. Paul, Gunnar Juliusson, H. Strander, C. Wedelin, Eva Kimby, B. Wadman, G. Brenning, A.-M. Stalfelt, Anders Ahre, G. Gahrton, Andreas Killander, Erik Svedmyr, Magnus Björkholm, Bengt Simonsson, M. Björeman, M. Järnmark, A.-M. Udén
Publikováno v:
European Journal of Haematology. 43:54-62
86 previously untreated patients with multiple myeloma stage III entered a randomized trial comparing combination chemotherapy (VMCP/VBAP) (n = 42) with intermittent oral melphalan and prednisone (MP) treatment (n = 44). The treatment gropus were wel
Autor:
Håkan Mellstedt, Gunnar Juliusson, Eva Ösby, Bengt Simonsson, Bengt Smedmyr, C. Paul, B. Wadman, Bertil Johansson, Erik Svedmyr, H. Strander, Magnus Björkholm, M. Björeman, H. Gyllenhammar, Andreas Killander, Karl Merk, G. Brenning, G. Grimfors, G. Gahrton, A.-M. Stalfelt, Eva Kimby, Richard A. Lerner, M. Järnmark, A.-M. Udén, Anders Österborg, R. Hast
Publikováno v:
European Journal of Haematology. 43:124-128
A randomized study comparing melphalan/prednisone (M/P) therapy with MP + natural alpha-IFN in untreated patients with multiple myeloma stages II and III started April 1, 1986. By March 1989, 78 patients were evaluable in the MP group and 80 in the M
Autor:
R. Lerner, A. Killander, Håkan Mellstedt, Åke Öst, A.-M. Stalfelt, B. Simonsson, B. Wadman, Eva Kimby, E. Svedmyr, K.-H. Robért, B. Johansson, Magnus Björkholm, Eva Löfvenberg, Bengt Glimelius, Anders Wahlin, Christer Sundström, Gunnar Juliusson, Hans Hagberg, M. Järnmark, Gösta Gahrton, A.-M. Udén, C. Lindemalm, H. Johansson, U. Pettersson
Publikováno v:
Annals of Oncology. 5:S67-S71
Two hundred fifty-nine previously untreated patients with low-grade non-Hodgkin's lymphomas (NHLs), Ann Arbor stages III and IV, entered a randomized multicenter trial comparing the therapeutic effect of chlorambucil/prednisone (ChP) vs. CHOP. All pa
Autor:
Berit Lönnqvist, Gunnar Grimfors, R. Lerner, J Palmblad, Gunnar Öberg, Per Ljungman, C. Nyström‐Rosander, M. Järnmark
Publikováno v:
Supportive Care in Cancer. 1:139-144
We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia. During the first induction therapy a double-blind,
Autor:
Carsten Peterson, Jan Liliemark, Eva Kimby, Jan Palmblad, Åke Öst, A.-M. Stalfelt, M. Järnmark, Ann-Marie Uden, Andreas Killander, D. Lockner, G. Gahrton, B. Lönnqvist, Magnus Björkholm, R. Lindquist, Håkan Mellstedt, Christer Paul, A. Lindeberg, Christer Sundström, C. Wedelin, Ulf Tidefelt, K. Merk, Bengt Simonsson, Gunnar Öberg, B. Wadman
Publikováno v:
Leukemia & Lymphoma. 3:355-364
In the light of previous findings that treatment of leukemia patients with DNA-linked doxorubicin gave higher doxorubicin concentrations in leukemic cells than treatment with doxorubicin alone, the Leukemia Group of Middle Sweden performed a randomiz
Autor:
E, Kimby, M, Björkholm, G, Gahrton, B, Glimelius, H, Hagberg, B, Johansson, H, Johansson, G, Juliusson, M, Järnmark, E, Löfvenberg
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 5
Two hundred fifty-nine previously untreated patients with low-grade non-Hodgkin's lymphomas (NHLs), Ann Arbor stages III and IV, entered a randomized multicenter trial comparing the therapeutic effect of chlorambucil/prednisone (ChP) vs. CHOP. All pa
Autor:
M. Järnmark, H. Gyllenhammar, A.-M. Udén, Bengt Smedmyr, G. Brenning, Kristina Carlson, Astrid Gruber, M. Ohrling, R. Hast, C. Paul, Anders Österborg, Fredrik Celsing, G. Gahrton, Bengt Simonsson, Eva Kimby, Olle Linder, Bertil Johansson, Gunnar Juliusson, Richard A. Lerner, M. Björeman, Karl Merk, Håkan Mellstedt, Eva Ösby, Erik Svedmyr, Magnus Björkholm, A.-M. Stalfelt, G. Grimfors
Publikováno v:
European journal of haematology. 51(1)
Fifty-six patients with refractory multiple myeloma were treated with intermittent courses of etoposide, doxorubicin, cyclophosphamide and high-dose betamethasone (EACB) every 4th week. The overall response rate was 30%. Durable remissions exceeding
Autor:
B, Lönnqvist, J, Palmblad, P, Ljungman, G, Grimfors, M, Järnmark, R, Lerner, C, Nyström-Rosander, G, Oberg
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 1(3)
We prospectively tested the hypothesis that prevention of herpes simplex virus infection with acyclovir might also reduce the incidence of bacterial infections in adult patients with acute leukaemia. During the first induction therapy a double-blind,
Autor:
G, Gahrton, U, Tidefelt, C, Paul, M, Björkholm, G, Grimfors, R, Hast, G, Juliusson, M, Järnmark, A, Killander, E, Kimby
Publikováno v:
Leukemia. 6